Current usage of explainer animations in trials: a survey of the UKCRC registered clinical trial units in the UK.
Journal article
Barber VS. et al, (2024), Trials, 25
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
Journal article
Kawano-Dourado L. et al, (2024), Thorax
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
Journal article
Hayward G. et al, (2024), J infect
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Journal article
Standing JF. et al, (2024), Nature communications, 15
Time to speed up scientific deliveries in fibrotic interstitial lung disease: Innovative clinical trial design to improve patient care
Journal article
RICHARDS D., (2024), Thorax
Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.
Journal article
Png ME. et al, (2024), Br j gen pract
Use of oxygen-loaded nanobubbles to improve tissue oxygenation: Bone-relevant mechanisms of action and effects on osteoclast differentiation.
Conference paper
Knowles HJ. et al, (2023), Biomaterials, 305
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Journal article
Weeratunga P. et al, (2023), Nat commun, 14
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2.
Journal article
Higham HE. et al, (2023), Br j clin pharmacol
Optimising Psoriatic Arthritis Therapy with Immunological Methods to Increase Standard Evaluation: The protocol of an open-label multi-centre, parallel-group, two arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Journal article
RICHARDS D., (2023), Bmj open
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.
Journal article
Gbinigie O. et al, (2023), Bmj open, 13
An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study
Journal article
Richards D. et al, (2022), Orphanet journal of rare diseases, 17
In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review.
Journal article
Drennan PG. et al, (2022), Clin transl sci
In vivo human keyhole limpet haemocyanin challenge in early phase drug development: A systematic review
Journal article
Drennan P. et al, (2022), Clinical and translational science
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Journal article
RICHARDS D., (2022), Nature reviews drug discovery
Corrigendum to 'Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes' [Surgery 171 (2021) 77-87].
Journal article
Shariq OA. et al, (2022), Surgery
COVID-19 therapeutics: challenges and directions for the future
Journal article
Robinson PC. et al, (2022), Proceedings of the national academy of sciences
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial.
Journal article
Dorward J. et al, (2022), Br j gen pract